| Flow Cytometry (MFI) | ||||||
|---|---|---|---|---|---|---|
| Cell Lines | HLA-A Allele | HLA-A02 | HLA-A24 | HER1 | HER2 | HER3 |
| ESCC | ||||||
| TE1 | 2402, 2601 | (−) | 36.2 | 122.5 | 85.2 | 23.0 |
| TE2 | 0206 | 399.8 | (−) | 74.7 | 44.7 | 27.7 |
| TE3 | 0206 | 944.4 | (−) | 207.3 | 34.0 | 30.5 |
| TE4 | 0207, 1101 | 50.9 | (−) | 31.2 | 577.4 | 48.0 |
| TE5 | 0206 | 1736.1 | (−) | 158.1 | 79.4 | 27.6 |
| KYSE30 | 0206, 2402 | 231.5 | 17.8 | 365.3 | 99.1 | 64.9 |
| KYSE50 | 0206 | 247.9 | (−) | 147.5 | 65.6 | 27.1 |
| KYSE110 | 0206 | 202.2 | (−) | 69.8 | 20.5 | 26.4 |
| Gastric cancer | ||||||
| MKN7 | 2402 | (−) | 31.9 | 156.4 | 970.0 | 23.2 |
| NCI-N87 | 2301 | (−) | 518.6a | 73.1 | 2737.1 | 30.8 |
| KATOIII | 0201, 0207 | 1309.8 | (−) | 62.2 | 247.5 | 51.7 |
| OE19 | 0201 | 73.7 | (−) | 36.9 | 774.8 | 85.4 |
| NUGC3 | 2402 | (−) | 76.6 | 88.3 | 45.5 | 24.5 |
| NUGC2 | 0207, 2404 | 104.9 | 24.3 | ND | 217.5 | ND |
| Breast cancer | ||||||
| BT474 | 0101, 2902 | (−) | (−) | 14.5 | 565.3 | ND |
| Epidermoid carcinoma | ||||||
| A431 | 0301 | (−) | (−) | 421.3 | 134.8 | ND |
↵a Anti–HLA-A24 mAb cross-reacts with the HLA-A23 molecule.
(−), Negative expression; ND, not determined.